Company Monitoring Page for Genentech

latest headlines for company on cafepharma

ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio
Endpoints
Sun, 12/12/21 - 11:31 pm
Tags:
ASH2021, Roche, Genentech, bispecific antibodies, blood cancer, mosunetuzumab
Life Sciences Expansions Take Off as 2021 Wraps Up
BioSpace
Thu, 12/9/21 - 10:35 am
Tags:
expansions, Novavax, Genentech, Mispro Biotech
Roche Signs Machine-Learning Neuroscience Deal With Recursion
Bloomberg
Tue, 12/7/21 - 10:53 am
Tags:
Roche, Genentech, artificial intelligence, machine learnings, Recursion Pharmaceuticals, cancer, Neuroscience
Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer
Xtalks
Wed, 10/27/21 - 10:58 am
Tags:
Genentech, Roche, ocular implant delivery, macular degeneration, FDA, wet age-related macular degeneration
FDA clears Roche’s Susvimo implant for eye disease wet AMD
Pharmaforum
Sun, 10/24/21 - 10:38 pm
Tags:
Roche, Genentech, FDA, Susvimo, wet age-related macular degeneration
Genentech study reveals health equity perception gap between patients and doctors
Fierce Pharma
Mon, 09/27/21 - 11:03 am
Tags:
Roche, Genentech, physicians, patients, racial disparity
After selling to Genentech, the old Jecure team is back at an RNA-focused startup — and more enthusiastic than ever
Endpoints
Tue, 09/21/21 - 10:47 am
Tags:
Genentech, Jecure Therapeutics, NASH, RNA, 858 Therapeutics
Biotech's 'founding father' and influential deal broker Fred Frank dies at 89
Endpoints
Mon, 09/13/21 - 10:31 am
Tags:
Fred Frank, Roche, Genentech, biotech
Demand for Genentech's Actemra increased 279% from June to August
Beckers Hospital Review
Thu, 08/26/21 - 08:35 pm
Tags:
Genentech, Actemra, COVID-19, monoclonal antibodies
Genentech Hemophilia A Drug Displays Long-term Safety, Efficacy
BioSpace
Mon, 07/19/21 - 11:09 pm
Tags:
Genentech, Hemlibra, hemophilia A, clinical trials
Ex-Genentech principal scientist, husband plead guilty in trade secrets case
Bizjournals
Thu, 07/8/21 - 11:43 pm
Tags:
Genentech, trade secrets
Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants its money back
Fierce Pharma
Mon, 06/28/21 - 06:53 pm
Tags:
Novartis, Genentech, California, Chiron
Roche Scores Wins in AMD & COVID-19 in Big Week
BioSpace
Sun, 06/27/21 - 12:02 am
Tags:
Roche, Genentech, COVID-19, wet age-related macular degeneration
Roche's Genentech launches new alliance aimed at achieving greater diversity in cancer trials
Fierce Biotech
Thu, 06/24/21 - 11:02 am
Tags:
Roche, Genentech, clinical trials, clinical trial diversity, cancer, Advancing Inclusive Research Site Alliance
A 'springboard' to the future: Genentech, Sanofi and Alnylam execs sound off on pharma's evolving back-to-work plans
Fierce Pharma
Wed, 05/26/21 - 12:05 am
Tags:
pandemic, COVID-19, Genentech, Sanofi, Alnylam, remote work, human resources
Roche's virtual gala raises multiple sclerosis awareness with celebrities—and personal connections
Fierce Pharma
Sun, 04/25/21 - 01:46 pm
Tags:
Roche, Genentech, pharma marketing, multiple sclerosis
Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
Pharmaforum
Thu, 04/15/21 - 10:02 am
Tags:
Roche, Genentech, Evrysdi, SMA
Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair
BioSpace
Tue, 04/13/21 - 10:03 pm
Tags:
Genentech, Novartis, FDA, Xolair, allergies
Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers
Fierce Pharma
Thu, 04/1/21 - 11:37 pm
Tags:
Roche, Genentech, diversity
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Fierce Pharma
Thu, 03/18/21 - 11:01 am
Tags:
Horizon Therapeutics, Roche, Genentech, AbbVie, Neurocrine, employee satisfaction

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.